📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Immunogenicity of one and two doses of Gardasil®9 in Tanzanian girls in the DoRIS Trial. (2025)

First Author: Kemp TJ

Attributed to: A Dose Reduction Immunobridging Study of two HPV vaccines in Tanzanian girls funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41541-025-01344-1

PubMed Identifier: 41419735

Publication URI: http://europepmc.org/abstract/MED/41419735

Type: Journal Article/Review

Volume: 11

Parent Publication: NPJ vaccines

Issue: 1

ISSN: 2059-0105